热门资讯> 正文
2025-10-28 19:05
NeoGenomics (NASDAQ: NEO) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.02 by 42.86 percent. This is a 40 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $187.797 million which beat the analyst consensus estimate of $183.770 million by 2.19 percent. This is a 11.90 percent increase over sales of $167.824 million the same period last year.